Pharma companies may get time till December to comply with schedule M norms

The government may extend the deadline for drug manufacturers to comply with revised Schedule M standards until December 2025. A final notification is expected soon, allowing MSMEs additional time to upgrade facilities.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/hplYXr3
via IFTTT